Show simple item record

dc.contributor.authorScott, James G
dc.contributor.authorMcKeon, Gemma
dc.contributor.authorMalacova, Eva
dc.contributor.authorCurtis, Jackie
dc.contributor.authorBurgher, Bjorn
dc.contributor.authorMacmillan, Iain
dc.contributor.authorThompson, Andrew
dc.contributor.authorParker, Stephen D
dc.date.accessioned2021-11-26T04:14:25Z
dc.date.available2021-11-26T04:14:25Z
dc.date.issued2021
dc.identifier.issn1039-8562en_US
dc.identifier.doi10.1177/10398562211054656en_US
dc.identifier.urihttp://hdl.handle.net/10072/410398
dc.description.abstractObjective: To present a practical, easy-to-implement clinical framework designed to support evidence-based quality prescribing for people with early psychosis. Method: Identification and explanation of key principles relating to evidence-based pharmacotherapy for people with early psychosis. These were derived from the literature, practice guidelines and clinical experience. Results: Key principles include (1) medication choice informed by adverse effects; (2) metabolic monitoring at baseline and at regular intervals; (3) comprehensive and regular medication risk–benefit assessment and psychoeducation; (4) early consideration of long-acting injectable formulations (preferably driven by informed patient choice); (5) identification and treatment of comorbid mood disorders and (6) early consideration of clozapine when treatment refractory criteria are met. Conclusions: Current prescribing practices do not align with the well-established evidence for quality pharmacotherapy in early psychosis. Adopting evidence-based prescribing practices for people with early psychosis will improve outcomes.en_US
dc.description.peerreviewedYesen_US
dc.languageEnglishen_US
dc.publisherSage Publications Ltden_US
dc.relation.ispartofjournalAustralasian Psychiatryen_US
dc.subject.fieldofresearchPsychologyen_US
dc.subject.fieldofresearchPsychopharmacologyen_US
dc.subject.fieldofresearchcode52en_US
dc.subject.fieldofresearchcode520205en_US
dc.subject.keywordsScience & Technologyen_US
dc.subject.keywordsLife Sciences & Biomedicineen_US
dc.subject.keywordsPsychiatryen_US
dc.subject.keywordsearly psychosisen_US
dc.subject.keywordsantipsychotic medicationsen_US
dc.titleQuality prescribing in early psychosis: key pharmacotherapy principlesen_US
dc.typeJournal articleen_US
dc.type.descriptionC1 - Articlesen_US
dcterms.bibliographicCitationScott, JG; McKeon, G; Malacova, E; Curtis, J; Burgher, B; Macmillan, I; Thompson, A; Parker, SD, Quality prescribing in early psychosis: key pharmacotherapy principles, Australasian Psychiatry, 2021en_US
dc.date.updated2021-11-24T00:39:28Z
gro.description.notepublicThis publication has been entered in Griffith Research Online as an advanced online version.en_US
gro.hasfulltextNo Full Text
gro.griffith.authorParker, Stephen D.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record